Last reviewed · How we verify
Botulinum purified neurotoxin, Type A
At a glance
| Generic name | Botulinum purified neurotoxin, Type A |
|---|---|
| Also known as | DWP-450 (Botulinum purified neurotoxin, Type A) Injection |
| Sponsor | Evolus, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
- COVID-19
- Headache
- INJECTION SITE BRUISING
- Nasopharyngitis
- NASOPHARYNGITIS
- Injection site bruising
- Injection site haematoma
- URI
- INJECTION SITE HAEMORRHAGE
- Sinusitis
- Eyelid Ptosis
- Lower respiratory tract infection
Key clinical trials
- Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor (PHASE2)
- Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin A Injection (NA)
- A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines (PHASE4)
- A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants (PHASE3)
- A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants (PHASE3)
- A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence (PHASE3)
- A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence (PHASE3)
- Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Botulinum purified neurotoxin, Type A CI brief — competitive landscape report
- Botulinum purified neurotoxin, Type A updates RSS · CI watch RSS
- Evolus, Inc. portfolio CI